|
Delayed
Nasdaq
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | - |
| 20/21/20 | Integra LifeSciences Holdings Corporation completed the acquisition of ACell, Inc for approximately $410 million. | CI |
| 22/20/22 | ACell, Inc. Announces CE Mark Approval | CI |
| Manager | Title | Age | Since |
|---|---|---|---|
Matthew R. Kunst
DFI | Director of Finance/CFO | - | 01/01/2020 |
Patty Meehan
ADM | Chief Administrative Officer | - | 01/01/2002 |
Jim Kuras
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Kyle C. Kerbawy
CHM | Chairman | 79 | 01/08/2015 |
Sally L. Maher
BRD | Director/Board Member | - | 01/05/2019 |
| Director/Board Member | 71 | 01/07/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 34Cr | |
| -0.31% | -1.94% | -24.39% | +2.91% | 17TCr | |
| +0.97% | -2.45% | -5.01% | +13.74% | 11TCr | |
| -1.01% | -4.01% | -1.04% | +66.14% | 5.8TCr | |
| +0.01% | +1.73% | -0.42% | -30.03% | 5.01TCr | |
| -1.00% | +0.37% | +14.24% | +51.55% | 5.01TCr | |
| +0.07% | -2.79% | +29.18% | -9.20% | 3.27TCr | |
| +1.07% | +9.73% | - | - | 3.08TCr | |
| +1.41% | +3.83% | +43.64% | -0.90% | 2.64TCr | |
| +1.39% | +6.40% | +28.38% | -2.83% | 2.4TCr | |
| Average | +0.23% | +1.43% | +10.57% | +11.42% | 5.62TCr | |
| Weighted average by Cap. | +0.12% | -0.18% | -2.67% | +12.45% |
| 2018 | 2019 | |
|---|---|---|
| Net sales | 8.92Cr 7.85Cr 7.42Cr 6.73Cr 13Cr 856.45Cr 13Cr 89Cr 34Cr 437.03Cr 33Cr 33Cr 1.4TCr | 10Cr 8.86Cr 8.38Cr 7.6Cr 14Cr 967.54Cr 14Cr 100.37Cr 39Cr 493.71Cr 38Cr 37Cr 1.59TCr |
| Net income | -31.31L -27.54L -26.04L -23.62L -44.36L -30Cr -44.62L -3.12Cr -1.2Cr -15Cr -1.18Cr -1.15Cr -49Cr | 14.49L 12.74L 12.05L 10.93L 20.52L 14Cr 20.64L 1.44Cr 55.71L 7.1Cr 54.39L 53.21L 23Cr |
| Net Debt | - | - |
Employees
-
- Stock Market
- Stocks
- ACLL Stock
Select your edition
All financial news and data tailored to specific country editions
